RIBOMIC Inc.

4591・Growth Market・Pharmaceuticals

Official website

RIBOMIC Inc.

4591・Growth Market・Pharmaceuticals

Official website

RIBOMIC Inc.4591

Reference Indicators

Market Cap

41¥100M

P/E (Forecast)

—

P/B

1.4x

Dividend Yield (Forecast)

0.00%

ROE

-40.3%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	80	65	—	2	3
SG&A Expenses	346	360	351	385	406
Operating Income	-1,748	-1,786	-1,116	-1,050	-1,207
Non-operating Income	115	147	137	40	82
Non-operating Expenses	2	10	3	4	13
Ordinary Income	-1,635	-1,649	-982	-1,014	-1,138
Extraordinary Income	—	0	—	—	—
Extraordinary Losses	48	3	40	2	5
Pre-tax Income	-1,683	-1,651	-1,023	-1,017	-1,144
Income Taxes	1	1	1	1	1
Net Income	-1,684	-1,653	-1,024	-1,018	-1,145
EBITDA	-1,732	-1,785	-1,105	-1,049	-1,203
Operating Margin	-2160.6%	-2707.4%	—	-49861.8%	-40237.7%
ROA	-34.0%	-36.1%	-28.9%	-32.0%	-38.5%
ROE	-35.9%	-37.7%	-30.2%	-33.5%	-40.3%